---
title: "Roivant Sciences Ltd. Stock 12‑Month Price Target Raised to $39.73, Implies 15% Upside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295155289.md"
description: "Roivant Sciences Ltd.'s 12-month average price target was raised to $39.73 by 11 analysts, up from $38.91, implying a 15% upside based on the Aug. 5 closing price. The consensus rating remains 'Buy' across 13 covering analysts, with 12 buys, 1 hold, and 0 sells."
datetime: "2026-08-06T23:20:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295155289.md)
  - [en](https://longbridge.com/en/news/295155289.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295155289.md)
generator: "portal-rs"
---

# Roivant Sciences Ltd. Stock 12‑Month Price Target Raised to $39.73, Implies 15% Upside

-   According to estimates from 11 analysts, Roivant Sciences Ltd. stock's average price target has risen from $38.91 to $39.73, with forecasts ranging from $34 to $50 per share
-   Based on the Aug. 5 closing price, the updated target implies approximately 15% potential upside
-   Consensus rating remains at “Buy” across 13 covering analysts, with 12 Buys, 1 Holds and 0 Sells

Explore more price target data and ratings for Roivant Sciences Ltd. on the , and track all previous and future analyst recommendations for Roivant Sciences Ltd. in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [ROIV.US](https://longbridge.com/en/quote/ROIV.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Roivant Sciences (NASDAQ:ROIV) Insider Sells 284,707 Shares](https://longbridge.com/en/news/296330990.md)
- [Roivant President, CIO Mayukh Sukhatme disposes of common shares worth $12.47 million](https://longbridge.com/en/news/296660931.md)
- [Roivant President, CIO Mayukh Sukhatme disposes of USD 24.12 million in common shares](https://longbridge.com/en/news/296284164.md)
- [Roivant Sciences President & CIO Sold Shares Worth Over $24M](https://longbridge.com/en/news/296285296.md)
- [Mayukh Sukhatme Sells 17,519 Shares of Roivant Sciences (NASDAQ:ROIV) Stock](https://longbridge.com/en/news/296663712.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**